Modelling nitrous and nitric oxide emissions by autotrophic ammonia-oxidizing bacteria

The emission of greenhouse gases, such as N2O, from wastewater treatment plants is a matter of growing concern. Denitrification by ammonia-oxidizing bacteria (AOB) has been identified as the main N2O producing pathway. To estimate N2O emissions during biological nitrogen removal, reliable mathematical models are essential. In this work, a mathematical model for NO (a precursor for N2O formation) and N2O formation by AOB is presented. Based on mechanistic grounds, two possible reaction mechanisms for NO and N2O formation are distinguished, which differ in the origin of the reducing equivalents needed for denitrification by AOB. These two scenarios have been compared in a simulation study, assessing the influence of the aeration/stripping rate and the resulting dissolved oxygen (DO) concentration on the NO and N2O emission from a SHARON partial nitritation reactor. The study of the simulated model behavior and its comparison with previously published experimental data serves in elucidating the true NO and N2O formation mechanism

Frailty is associated with in-hospital mortality in older hospitalised COVID-19 patients in the Netherlands:the COVID-OLD study

BACKGROUND: During the first wave of the coronavirus disease 2019 (COVID-19) pandemic, older patients had an increased risk of hospitalisation and death. Reports on the association of frailty with poor outcome have been conflicting. OBJECTIVE: The aim of the present study was to investigate the independent association between frailty and in-hospital mortality in older hospitalised COVID-19 patients in the Netherlands. METHODS: This was a multicentre retrospective cohort study in 15 hospitals in the Netherlands, including all patients aged ≥70 years, who were hospitalised with clinically confirmed COVID-19 between February and May 2020. Data were collected on demographics, co-morbidity, disease severity and Clinical Frailty Scale (CFS). Primary outcome was in-hospital mortality. RESULTS: A total of 1,376 patients were included (median age 78 years (interquartile range 74-84), 60% male). In total, 499 (38%) patients died during hospital admission. Parameters indicating presence of frailty (CFS 6-9) were associated with more co-morbidities, shorter symptom duration upon presentation (median 4 versus 7 days), lower oxygen demand and lower levels of C-reactive protein. In multivariable analyses, the CFS was independently associated with in-hospital mortality: compared with patients with CFS 1-3, patients with CFS 4-5 had a two times higher risk (odds ratio (OR) 2.0 (95% confidence interval (CI) 1.3-3.0)) and patients with CFS 6-9 had a three times higher risk of in-hospital mortality (OR 2.8 (95% CI 1.8-4.3)). CONCLUSIONS: The in-hospital mortality of older hospitalised COVID-19 patients in the Netherlands was 38%. Frailty was independently associated with higher in-hospital mortality, even though COVID-19 patients with frailty presented earlier to the hospital with less severe symptoms

Effect of angiotensin-converting enzyme inhibitor and angiotensin receptor blocker initiation on organ support-free days in patients hospitalized with COVID-19

IMPORTANCE Overactivation of the renin-angiotensin system (RAS) may contribute to poor clinical outcomes in patients with COVID-19. Objective To determine whether angiotensin-converting enzyme (ACE) inhibitor or angiotensin receptor blocker (ARB) initiation improves outcomes in patients hospitalized for COVID-19. DESIGN, SETTING, AND PARTICIPANTS In an ongoing, adaptive platform randomized clinical trial, 721 critically ill and 58 non–critically ill hospitalized adults were randomized to receive an RAS inhibitor or control between March 16, 2021, and February 25, 2022, at 69 sites in 7 countries (final follow-up on June 1, 2022). INTERVENTIONS Patients were randomized to receive open-label initiation of an ACE inhibitor (n = 257), ARB (n = 248), ARB in combination with DMX-200 (a chemokine receptor-2 inhibitor; n = 10), or no RAS inhibitor (control; n = 264) for up to 10 days. MAIN OUTCOMES AND MEASURES The primary outcome was organ support–free days, a composite of hospital survival and days alive without cardiovascular or respiratory organ support through 21 days. The primary analysis was a bayesian cumulative logistic model. Odds ratios (ORs) greater than 1 represent improved outcomes. RESULTS On February 25, 2022, enrollment was discontinued due to safety concerns. Among 679 critically ill patients with available primary outcome data, the median age was 56 years and 239 participants (35.2%) were women. Median (IQR) organ support–free days among critically ill patients was 10 (–1 to 16) in the ACE inhibitor group (n = 231), 8 (–1 to 17) in the ARB group (n = 217), and 12 (0 to 17) in the control group (n = 231) (median adjusted odds ratios of 0.77 [95% bayesian credible interval, 0.58-1.06] for improvement for ACE inhibitor and 0.76 [95% credible interval, 0.56-1.05] for ARB compared with control). The posterior probabilities that ACE inhibitors and ARBs worsened organ support–free days compared with control were 94.9% and 95.4%, respectively. Hospital survival occurred in 166 of 231 critically ill participants (71.9%) in the ACE inhibitor group, 152 of 217 (70.0%) in the ARB group, and 182 of 231 (78.8%) in the control group (posterior probabilities that ACE inhibitor and ARB worsened hospital survival compared with control were 95.3% and 98.1%, respectively). CONCLUSIONS AND RELEVANCE In this trial, among critically ill adults with COVID-19, initiation of an ACE inhibitor or ARB did not improve, and likely worsened, clinical outcomes. TRIAL REGISTRATION ClinicalTrials.gov Identifier: NCT0273570

Metabolic modeling of denitrification in Agrobacterium tumefaciens: A tool to study inhibiting and activating compounds for the denitrification pathway

A metabolic network model for facultative denitrification was developed based on experimental data obtained with Agrobacterium tumefaciens. The model includes kinetic regulation at the enzyme level and transcription regulation at the enzyme synthesis level. The objective of this work was to study the key factors regulating the metabolic response of the denitrification pathway to transition from oxic to anoxic respiration and to find parameter values for the biological processes that were modeled. The metabolic model was used to test hypotheses that were formulated based on the experimental results and offers a structured look on the processes that occur in the cell during transition in respiration. The main phenomena that were modeled are the inhibition of the cytochrome c oxidase by nitric oxide (NO) and the (indirect) inhibition of oxygen on the denitrification enzymes. The activation of transcription of nitrite reductase and NO reductase by their respective substrates were hypothesized. The general assumption that nitrite and NO reduction are controlled interdependently to prevent NO accumulation does not hold for A. tumefaciens. The metabolic network model was demonstrated to be a useful tool for unraveling the different factors involved in the complex response of A. tumefaciens to highly dynamic environmental conditions.BT/BiotechnologyApplied Science

Modelling nitrous and nitric oxide emissions by autotrophic ammonium oxidizing bacteria

In this work, a mathematical model has been set up to describe NO and N2O formation by autotrophic ammonium oxidizing bacteria in a partial nitritation (SHARON) reactor. Based on mechanistic grounds, two possible reaction mechanisms for NO and N2O formation were proposed. These two scenarios have subsequently been compared in a simulation study. The influence of intermittent versus continuous aeration on NO and N2O formation for the same aerated retention time has been addressed as well. Applying continuous aeration a maximal N2O formation was found at intermediate dissolved oxygen (DO) concentrations of about 2 mg O2.l-1

Nitrous and nitric oxides and the effect of oxygen level and nitrite concentration on its emission from nitritation and nitrification-denitrification reactors

Two different laboratory scale experiments were performed to evaluate nitric oxide (NO) and nitrous oxide (N2O) production from ammonium-rich wastewater using both continuous stirred tank reactor (CSTR) and sequencing batch reactor (SBR). A nitritation reactor (CSTR) based on a Sharon (Single reactor system for High activity Ammonium Removal Over Nitrite) process was used for the partial nitrification of 1000 mg per liter of ammonium-nitrogen (NH4-N) resulting in a high concentration of nitrite-nitrogen (NO2-N) in the reactor while a 12-hour cycle SBR with anoxic-aerobic phases was used for the complete nitrification and denitrification of 340 mg per liter ammonium-nitrogen of wastewater. Concentrations of NO and N2O were measured from these reactors and the results showed that nitrite concentration in the reactor has significant effect on the production of NO and N2O for both CSTR and SBR. On the other hand, oxygen level also has a significant effect on the emission of NO and N2O observed in the two reactors. When no oxygen is supplied to the reactor, both NO and N2O concentrations in the off gas rise sharply while Upon gradual lowering of the DO in the reactor, the NO level decreases, but the N2O level increases. © 2008 IEEE

Effect of Nitric Oxide on Anammox Bacteria▿

The effects of nitrogen oxides on anammox bacteria are not well known. Therefore, anammox bacteria were exposed to 3,500 ppm nitric oxide (NO) in the gas phase. The anammox bacteria were not inhibited by the high NO concentration but rather used it to oxidize additional ammonium to dinitrogen gas under conditions relevant to wastewater treatment

Unraveling the Source of Nitric Oxide Emission During Nitrification

BiotechnologyApplied Science